✦ LIBER ✦

Mammary tumor modifiers in BALB/cJ mice heterozygous forp53

✍ Scribed by Joanna G. Koch; Xiangjun Gu; Younghun Han; Adel K. El-Naggar; Melissa V. Olson; Daniel Medina; D. Joseph Jerry; Anneke C. Blackburn; Gary Peltz; Christopher I. Amos; Guillermina Lozano

Publisher: Springer-Verlag
Year: 2007
Tongue: English
Weight: 243 KB
Volume: 18
Category: Article
ISSN: 0938-8990
DOI: 10.1007/s00335-007-9028-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infrequent p53 mutations in 7,12-dimethy

Infrequent p53 mutations in 7,12-dimethylbenz[a]anthracene–induced mammary tumors in BALB/c and p53 hemizygous mice

✍ D. Joseph Jerry; Janet S. Butel; Lawrence A. Donehower; Emily J. Paulson; Charle 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 804 KB

## Abstract We conducted experiments to determine if __p53__ alterations, which are frequent in human breast cancers, were also common in murine mammary tumors. In 13 mammary tumors from 7,12‐dimethylbenz[__a__]anthracene (DMBA)‐treated BALB/c mice were immunohistochemically analyzed for overexpres

5-Chlorodeoxycytidine, a radiosensitizer

5-Chlorodeoxycytidine, a radiosensitizer effective against RIF-1 and lewis lung carcinoma, is also effective against a DMBA-induced mammary adenocarcinoma and the EMT-6 tumor in BALB/c mice

✍ Sheldon Greer; Orlando Santos; Charles Gottlieb; James Schwade; H. Stan Marion 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 723 KB